Correlation Between Tcr2 Therapeutics and Design Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tcr2 Therapeutics and Design Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tcr2 Therapeutics and Design Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tcr2 Therapeutics and Design Therapeutics, you can compare the effects of market volatilities on Tcr2 Therapeutics and Design Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tcr2 Therapeutics with a short position of Design Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tcr2 Therapeutics and Design Therapeutics.
Diversification Opportunities for Tcr2 Therapeutics and Design Therapeutics
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Tcr2 and Design is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Tcr2 Therapeutics and Design Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Design Therapeutics and Tcr2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tcr2 Therapeutics are associated (or correlated) with Design Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Design Therapeutics has no effect on the direction of Tcr2 Therapeutics i.e., Tcr2 Therapeutics and Design Therapeutics go up and down completely randomly.
Pair Corralation between Tcr2 Therapeutics and Design Therapeutics
If you would invest 541.00 in Design Therapeutics on August 30, 2024 and sell it today you would earn a total of 56.00 from holding Design Therapeutics or generate 10.35% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 4.35% |
Values | Daily Returns |
Tcr2 Therapeutics vs. Design Therapeutics
Performance |
Timeline |
Tcr2 Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Design Therapeutics |
Tcr2 Therapeutics and Design Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tcr2 Therapeutics and Design Therapeutics
The main advantage of trading using opposite Tcr2 Therapeutics and Design Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tcr2 Therapeutics position performs unexpectedly, Design Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will offset losses from the drop in Design Therapeutics' long position.Tcr2 Therapeutics vs. Affimed NV | Tcr2 Therapeutics vs. Pieris Pharmaceuticals | Tcr2 Therapeutics vs. ADC Therapeutics SA | Tcr2 Therapeutics vs. Agenus Inc |
Design Therapeutics vs. Monte Rosa Therapeutics | Design Therapeutics vs. Werewolf Therapeutics | Design Therapeutics vs. Ikena Oncology | Design Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |